Ayca Yildiz Pekoz - Istanbul University

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 20 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Association Between Culture and the Preference For, and Perceptions Of, 11 Routes of Medicine Administration: A Survey in 21 Countries and Regions

Exploratory Research in Clinical and Social Pharmacy (2023): 100378-100378

引用0浏览0WOS引用

Lung Microbiota: Its Relationship to Respiratory System Diseases and Approaches for Lung-Targeted Probiotic Bacteria Delivery

Nilufer Yuksel, Busra Gelmez,Ayca Yildiz-Pekoz

Molecular pharmaceuticsno. 7 (2023): 3320-3337

引用5浏览0WOS引用

Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment

Gokben Sahin,Ozlem Akbal-Dagistan,Meltem Culha,Aybige Erturk,Nur Sena Basarir,Serap Sancar,Ayca Yildiz-Pekoz

Journal of pharmaceutical sciences（2022）

引用13浏览0WOS引用

Development and Evaluation of Combined Effect Buccal Films for Treatment of Oral Candidiasis

Derya Arslan,Özlem Akbal Dağıstan,Olcay Sagirli,Lutfiye Mulazimoglu,Erdal Cevher,Ayca Yildiz-Pekoz

AAPS PharmSciTechno. 1 (2022)

引用2浏览0WOS引用

Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects

Ozlem Akbal-Dagistan,Mustafa Sevim,Leyla Semiha Sen,Nur Sena Basarir,Meltem Culha,Aybige Erturk,Hanan Fael,Engin Kaptan,Serap Sancar,Lutfiye Mulazimoglu Durmusoglu,Berrak C. Yegen,Ayca Yildiz-Pekoz

PHARMACEUTICS（2022）

引用1浏览0WOS引用

Pulmonary Delivery of Favipiravir Inhalation Solution for COVID-19 Treatment: in Vitro Characterization, Stability, in Vitro Cytotoxicity, and Antiviral Activity Using Real Time Cell Analysis

Ayca Yildiz Pekoz,Ozlem Akbal Dagistan,Hanan Fael,Meltem Culha,Aybige Erturk,Nur Sena Basarir,Gokben Sahin,Muge Serhatli,Gamze Cakirca,Saban Tekin,Leyla Semiha Sen,Mustafa Sevim,Lutfiye Mulazimoglu Durmusoglu,Berrak C. Yegen

Drug Delivery（2022）

引用5浏览0WOS引用

Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial

Mustafa Erelel,Mert Kaskal,Ozlem Akbal-Dagistan,Halim Issever, Ahmet Serhan Dagistanli, Hilal Balkanci,Merve Sinem Oguz, Aygun Qarayeva,Meltem Culha,Aybige Erturk,Nur Sena Basarir,Gokben Sahin,Ali Yagiz Uresin,Ahmet Ogul Araman,Alpay Medetalibeyoglu,Tufan Tukek,Mustafa Oral Oncul,Ayca Yildiz-Pekoz

Pharmaceutics（2021）

引用11浏览0WOS引用

Advances in Pulmonary Drug Delivery

Ayca Yıldız-Peköz,Carsten Ehrhardt

Pharmaceuticsno. 10 (2020): 911

引用29浏览0引用

New Dosage Forms: Oral Films

Ece ÖZCAN BÜLBÜL,Ayca YILDIZ PEKÖZ,Yıldız ÖZSOY

Journal of Literature Pharmacy Sciencesno. 3 (2019): 171-184

引用0浏览0引用

Pulmonary Delivery of Nanocomposite Microparticles (ncmps) Incorporating Mir-146A for Treatment of COPD

Adel Mohamed,Ayca Y. Pekoz,Kehinde Ross,Gillian A. Hutcheon,Imran Y. Saleem

International Journal of Pharmaceutics（2019）

引用35浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn